Cargando…
Two Independent Hematological malignancies in a B-Cell Deficient Good Syndrome Patient
Autores principales: | Koning, Marvyn T, van Rossum, André P, Tiren-Verbeet, Nicolette L, Burgers, Jacobus A, Karim, A Faiz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023981/ https://www.ncbi.nlm.nih.gov/pubmed/33188420 http://dx.doi.org/10.1093/rheumatology/keaa666 |
Ejemplares similares
-
Meta-Analysis on Impact of Rituximab in Patients with Hematological Malignancies with Covid-19 Infection
por: Vegivinti, Charan Thej Reddy, et al.
Publicado: (2022) -
Hematologic Outcomes of COVID-19 Patients with and without G6PD Deficiency: A Comparative Study
por: Yassin, Mohamed A, et al.
Publicado: (2022) -
A 72-year-old man with life-threatening dyspnoea due to a neck mass of unexpected origin
por: Schubert, Nick M.A., et al.
Publicado: (2021) -
Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022) -
Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
por: Suruki, Robert Y, et al.
Publicado: (2022)